Comparing the current results to its competitors, Koru Medical Systems Inc reported Revenue increase in the 2 quarter 2026 by 18.15 % year on year. The sales growth was above Koru Medical Systems Inc 's competitors' average revenue growth of 5.46 %, achieved in the same quarter.
Overall company sales advanced by 18.15 % Koru Medical Systems Inc outperformed its competitors in this segment and improved market share, to approx. 0.04 %. << More on KRMD Market Share.
*Market share is calculated based on total revenue.
March 6, 2024
KORU Medical Systems Partners with Pharma Giant for Novel Subcutaneous Immunoglobulin Trial; Poised for Breakthrough in Patient-Centric Infusion SolutionsMAHWAH, N.J. - KORU Medical Systems, Inc. (NASDAQ: KRMD), a leading medical technology company specializing in the development and commercialization of patient-centric large volume subcutaneous infusion solutions, has announced a groundbreaking clinical supply agreement with a prominent pharmaceutical partner. This collaboration will facilitate the Phase 3 trial of a novel subcutaneous immunoglobulin (SCIg) drug, with KORU Medical s custom device playing a vital role in delivering this groundbreaking therapy. The agreement is a significant milestone for bot...
KORU Medical Systems, Inc. (NASDAQ: KRMD) recently revealed a significant development agreement with a prominent biopharmaceutical manufacturer. The agreement entails the development and regulatory approval of a cutting-edge subcutaneous immunoglobulin infusion system. This endeavor underscores KORU Medical s commitment to enhancing the lives of patients through the provision of innovative and user-friendly specialty subcutaneous infusion solutions. Decrease in Revenue: In the third quarter of 2023, KORU Medical Systems Inc reported a year-on-year decline in revenue by 9.76%. Interestingly, this decline outpaced the decrease recorded by its competitors, indicating a potential competitive ad...
Avanos Medical Inc's business model focuses on the development, manufacturing, and distribution of medical devices and technology solutions for various healthcare applications.
ResMed Inc is a medical equipment company focused on creating and manufacturing products for the treatment of sleep apnea and other respiratory conditions. Their business model includes a combination of direct sales and partnerships with healthcare providers, ensuring wide distribution of their devices to patients worldwide. By leveraging advanced technology and data-driven solutions, ResMed aims to enhance patient care and improve health outcomes for individuals with sleep-related breathing issues.
West Pharmaceutical Services Inc Share Performance
+5.66%
30 Days
West Pharmaceutical Services Inc
Profile
West Pharmaceutical Services Inc operates as a global manufacturer and supplier of innovative packaging and delivery systems for the pharmaceutical and biotech sectors. Their business model focuses on providing comprehensive solutions, including drug administration systems and customer support, to ensure safe and efficient delivery of medications to patients.
Baxter International Inc is a global healthcare company that specializes in providing a wide range of medical products and services. They operate through various business segments including Pharmaceuticals, Medical Products, and Renal Care, offering solutions for hospitals, clinics, and home-based healthcare settings.
Sources:
Koru Medical Systems Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Koru Medical Systems Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
